Regular Article
Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritis

https://doi.org/10.1053/berh.1999.0054Get rights and content

Abstract

Pharmacotherapy is still the cornerstone in the management of rheumatoid arthritis (RA). Due to several reasons the pharmacotherapeutic strategy has changed dramatically in the past decades. It has become clear that in most cases single treatment with disease modifying anti rheumatic drugs (DMARDs) is insufficient to control the disease on the long term. This is the main reason why combinations of second-line agents are increasingly being used in the treatment of established RA. Many different ways of prescribing combination treatment and a large number of different combinations have been published. However definite conclusions which drugs to combine or what strategy to apply are difficult to make as solid studies which enable these conclusions are sparse. Several studies have shown that the best opportunity to achieve a good response is to use a set-up approach, in addition different studies have shown that corticosteroids do have a profound effect on disease activity variables.

References (58)

  • L BA van de Putte et al.

    Early treatment of rheumatoid arthritis: rationale, evidence, and implication

    Annals of Rheumatic Disease

    (1998)
  • A Brook et al.

    Radiographic changes in early rheumatoid arthritis

    Annals of Rheumatic Disease

    (1977)
  • D MFM van der Heijde et al.

    Biannual radiographic assessments of hands and feet in a three year prospective follow-up of patients with early rheumatoid arthritis

    Arthritis and Rheumatism

    (1992)
  • A van der Heide et al.

    The effectiveness of early treatment with ‘second-line’ antirheumatic drugs. A randomized, controlled trial

    Annals of International Medicine

    (1996)
  • F Wolfe et al.

    Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts

    Journal of Rheumatology

    (1990)
  • MJ Wijnands et al.

    Long-term second-line treatment: a prospective drug survival study

    British Journal of Rheumatology

    (1992)
  • ME Suarez-Almazor

    Practice patterns in the management of rheumatoid arthritis, increased use of combination therapy

    Arthritis and Rheumatism

    (1998)
  • B WE Wang et al.

    Frequency of two-DMARD combinations in the treatment of rheumatoid arthritis (RA)

    Arthritis and Rheumatism

    (1998)
  • LW Moreland et al.

    Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

    New England Journal of Medicine

    (1997)
  • DE Furst

    Combination DMARD therapy: rationale and limitations

    Rheumatology in Europe

    (1995)
  • HJ Williams et al.

    Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis, a controlled clinical trial

    Arthritis and Rheumatism

    (1992)
  • KL Faarvang et al.

    Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial

    Annals of Rheumatic Diseases

    (1993)
  • MB Ferraz et al.

    Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A randomized placebo-controlled trial

    Scandinavian Journal of Rheumatology

    (1994)
  • M Farr et al.

    Sulphasalazine in rheumatoid arthritis, combination therapy with D-penicillamine or sodium aurothiomalate

    Clinical Rheumatology

    (1988)
  • R FJM Laan et al.

    Glucocorticosteroids in the management of rheumatoid arthritis

    Rheumatology

    (1999)
  • JR Kirwan

    The effect of glucocorticosteroids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council low-dose Glucocorticosteroid Study Group

    New England Journal of Medicine

    (1995)
  • E Morrison et al.

    Corticosteroids in rheumatoid arthritis—the case against

    Rheumatology

    (1999)
  • CJ Haagsma et al.

    Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response

    British Journal of Clinical Pharmacology

    (1996)
  • Cited by (9)

    View all citing articles on Scopus
    View full text